370 related articles for article (PubMed ID: 19844216)
1. Nephropharmacology: drugs and the kidney.
Atkinson AJ; Huang SM
Clin Pharmacol Ther; 2009 Nov; 86(5):453-6. PubMed ID: 19844216
[No Abstract] [Full Text] [Related]
2. Use of the MDRD study equation to estimate kidney function for drug dosing.
Stevens LA; Levey AS
Clin Pharmacol Ther; 2009 Nov; 86(5):465-7. PubMed ID: 19844220
[No Abstract] [Full Text] [Related]
3. "Getting the dose right": facts, a blueprint, and encouragements.
Peck CC; Cross JT
Clin Pharmacol Ther; 2007 Jul; 82(1):12-4. PubMed ID: 17571068
[No Abstract] [Full Text] [Related]
4. Continuing the use of the Cockcroft-Gault equation for drug dosing in patients with impaired renal function.
Spruill WJ; Wade WE; Cobb HH
Clin Pharmacol Ther; 2009 Nov; 86(5):468-70. PubMed ID: 19844221
[No Abstract] [Full Text] [Related]
5. [Dosages of drugs in patients with kidney function disorders].
Verresen L
Ned Tijdschr Geneeskd; 1991 Mar; 135(13):547-51. PubMed ID: 2027403
[No Abstract] [Full Text] [Related]
6. Drug dosing in patients with impaired renal function.
Brater DC
Clin Pharmacol Ther; 2009 Nov; 86(5):483-9. PubMed ID: 19626002
[TBL] [Abstract][Full Text] [Related]
7. [Dosage of drugs with regard to their distribution volume and biological half-life].
Dahl SG
Tidsskr Nor Laegeforen; 1974 Jun; 94(18):1201-2. PubMed ID: 4839999
[No Abstract] [Full Text] [Related]
8. [Adjusting dosage of drugs in patients with kidney or liver failure].
Krähenbühl S
Schweiz Med Wochenschr; 1998 Feb; 128(6):189-94. PubMed ID: 9540139
[TBL] [Abstract][Full Text] [Related]
9. Precision versus approximation: the trade off in assessing kidney function and drug dosing.
Richardson MM
Pharmacotherapy; 2010 Aug; 30(8):758-61. PubMed ID: 20653350
[No Abstract] [Full Text] [Related]
10. [Pharmacokinetics as a basic pharmacological problem].
Dettli L
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():59-73. PubMed ID: 4906026
[No Abstract] [Full Text] [Related]
11. [Drugs in elderly institutionalized patients with renal failure].
Recio Blázquez ML; Puebla García V; Manzano Lorenzo R
Farm Hosp; 2010; 34(3):156; author reply 157-8. PubMed ID: 20359925
[No Abstract] [Full Text] [Related]
12. Variation in response to drugs: Part I. Patient, physiological and disease variables.
Fraser HS; Tibbits RC
West Indian Med J; 1983 Mar; 32(1):7-16. PubMed ID: 6346692
[No Abstract] [Full Text] [Related]
13. A comment on "grapefruit-drug interactions: can interactions with drugs be avoided?".
Blum RS
J Clin Pharmacol; 2007 Apr; 47(4):536; author reply 537. PubMed ID: 17389562
[No Abstract] [Full Text] [Related]
14. Pharmacology.
Perazella MA; Parikh C
Am J Kidney Dis; 2005 Dec; 46(6):1129-39. PubMed ID: 16310580
[No Abstract] [Full Text] [Related]
15. When to conduct a renal impairment study during drug development: US Food and Drug Administration perspective.
Huang SM; Temple R; Xiao S; Zhang L; Lesko LJ
Clin Pharmacol Ther; 2009 Nov; 86(5):475-9. PubMed ID: 19844224
[TBL] [Abstract][Full Text] [Related]
16. [Renal injury from drugs].
Sugisaki T
Nihon Rinsho; 2006 Feb; 64 Suppl 2():597-602. PubMed ID: 16523962
[No Abstract] [Full Text] [Related]
17. [The effect of disease on pharmacokinetics of drugs. 1. Kidney diseases].
Pfeifer S
Pharmazie; 1991 May; 46(5):305-27. PubMed ID: 1896477
[No Abstract] [Full Text] [Related]
18. [How to adjust the dose of drugs in chronic kidney disease?].
Launay-Vacher V; Janus N; Zimner-Rapuch S; Amet S; Deray G
Rev Prat; 2012 Mar; 62(3):309-11, 314-5. PubMed ID: 22514978
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics and administration of drugs in patients with hepatic failure].
Yamada S; Suou T
Nihon Rinsho; 2007 Oct; 65 Suppl 8():53-7. PubMed ID: 18074517
[No Abstract] [Full Text] [Related]
20. Pharmacogenetics: improving drug and dose selection.
Bhathena A; Spear BB
Curr Opin Pharmacol; 2008 Oct; 8(5):639-46. PubMed ID: 18762278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
